Australia markets open in 6 hours 35 minutes

Thiogenesis Therapeutics, Corp. (TTI.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.68000.0000 (0.00%)
As of 01:08PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
28/02/2022
28/02/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
-
Operating expenses
Research development
3,858
4,163
1,076
-
-
499.702
116.4383
Selling general and administrative
1,094
1,043
933.087
218.21
89.029
-
-
Total operating expenses
4,952
5,206
1,975
224.678
92.653
-
-
Operating income or loss
-4,952
-5,206
-1,975
-224.678
-92.653
-
-
Interest expense
-
0
4.123
0.026
0.025
-
-
Total other income/expenses net
-
-28.155
-1,951
-
-
-
-
Income before tax
-4,707
-5,063
-3,924
-224.457
-92.678
-
-
Income from continuing operations
-4,707
-5,063
-3,924
-224.457
-92.678
-
-
Net income
-4,707
-5,063
-3,924
-224.457
-92.678
-
-
Net income available to common shareholders
-4,707
-5,063
-3,924
-224.457
-92.678
-
-
Basic EPS
-0.04
-0.13
-0.16
-0.01
-0.01
-
-
Diluted EPS
-0.04
-0.13
-0.16
-0.01
-0.01
-
-
Basic average shares
27,910
39,129
25,292
27,910
12,000
-
-
Diluted average shares
27,910
39,129
25,292
27,910
12,000
-
-